1. Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15). Issue 3 (5th December 2017) Authors: McCaughan, G. W.; Thwaites, P. A.; Roberts, S. K.; Strasser, S. I.; Mitchell, J.; Morales, B.; Mason, S.; Gow, P.; Wigg, A.; Tallis, C.; Jeffrey, G.; George, J.; Thompson, A. J.; Parker, F. C.; Angus, P. W. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 3(2018) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗